Skip to content

Efficacy of oral tolerance induction by Kakkonto in food allergy - Non-Randomized clinical trial-

Efficacy of oral tolerance induction by Kakkonto in food allergy - Non-Randomized clinical trial- - Efficacy of Kakkonto for food allergy

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs041180068
Enrollment
60
Registered
2019-03-07
Start date
2017-12-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Food allergy Food allergy

Interventions

Sponsors

Nomura Keiko
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Food allergy diagnosised by oral food challenge without tendency of natural outgrow 2. Children who obtain the informed consent of the study 3. Those who can take medicine of kakkonto 4. Patients who have secured medical institutions in emergency

Exclusion criteria

Exclusion criteria: 1.Complication or past history of heart, liver and kidney diseases. 2.Uncontrolled asthma, atopic dermatitis, allergic rhinitis 3.Children who were judged as inappropriate by the study director

Design outcomes

Primary

MeasureTime frame
1. Induced reaction during 24 weeks of treatment 2. Change of dose threshold in oral food challenge after 24 weeks of treatment 3. adverse reaction of kakkonto

Secondary

MeasureTime frame
1. Specific IgE/IgG4 antibody,cytokines,lymphocytes subsets 2. Compliance of kakkonto

Contacts

Public ContactTaisuke Kato

Toyama University Hospital

yaitto-tym@umin.net+81-76-434-7313

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026